nikolaos-papanas
Nikolaos Papanas, PhD
Associate Professor in Internal Medicine

Education


Biography

Dr. Nikolaos Papanas is Associate Professor in Internal Medicine-Diabetes Mellitus at Democritus University of Thrace, Greece. He has been specialized in diabetes and its complications in the Diabetes Center and the Diabetic Foot Clinic at King’s College Hospital, London, UK, as well as in the German Diabetes Center at the Heinrich Heine University, Düsseldorf, Germany. He has established an ongoing collaboration with the neuropathy study group of the German Diabetes Center in Düsseldorf. He has published more than 250 papers in peer-reviewed journals with more than 3000 citations. He serves in the editorial board of more than 40 international journals. He has also participated with numerous presentations in Greek and European medical congresses and repeatedly served as invited reviewer in medical journals. He has served in the Executive Committee of the Hellenic Society for Angiology. He is currently a member in the Executive Committee of the Study Group on Diabetes and Nervous System of the German Diabetes Association (DDG). He is also a member of the Executive Committee of the Greek Society for the Study of the Diabetic Foot. He has served as Secretary General and, until very recently, as President of the Hellenic Diabetes Association. He is now the President of the ethics and administrative committee of the Hellenic Diabetes Association. He is also Vice President of the Diabetic Foot Study Group (DFSG, www.dfsg.org) of the European Association for the Study of Diabetes (EASD). He has recently become Visiting Professor, German Diabetes Centre, Düsseldorf. Finally, he is an honorary member of the Cypriot Diabetes Association and the Hungarian Diabetes Association.


Research Interest

  • Diabetes mellitus
  • Diabetic complications
  • Diabetic foot
  • Diabetic neuropathy
  • Medical writing
  • Vascular disease
  • Metabolic syndrome in OSAS and obesity

Scientific Activities

Employment History
present Associate Professor in Internal Medicine-Diabetes Mellitus at Democritus University of Thrace, Greece
Teaching in postgraduate courses  Teaching contribution to the Post-graduate Course of specialisation in LiverPancreas-Biliary Surgery of the Second Department of Surgery, Democritus University of Thrace
   Teaching contribution to the Post-graduate Course of Hygiene and Safety at the Workplace of the Laboratory of Hygiene and Environmental Protection at Democritus University of Thrace and the Department of Nursing, Athens University
Professional Activities

Membership in Scientific/Professional Organizations

  • He serves in the editorial board of more than 40 international journals.
  • He has also participated with numerous presentations in Greek and European medical congresses and repeatedly served as invited reviewer in medical journals.
  • He has served in the Executive Committee of the Hellenic Society for Angiology
  • He is also a member of the Executive Committee of the Greek Society for the Study of the Diabetic Foot.
  • He has served as Secretary General and, until very recently, as President of the Hellenic Diabetes Association.
  • He is now the President of the ethics and administrative committee of the Hellenic Diabetes Association. He is also Vice President of the Diabetic Foot Study Group (DFSG, www.dfsg.org) of the European Association for the Study of Diabetes (EASD).
  • He has recently become Visiting Professor, German Diabetes Centre, Düsseldorf.
  • Finally, he is an honorary member of the Cypriot Diabetes Association and the Hungarian Diabetes Association.
Honors and Awards
  • Neuropathy Study Group of the German Diabetes Association (May 2012-Present)
  • Diabetic Foot Study Group (DFSG) of the European Association for the Study of Diabetes (September 2012-Present)

Publications

  1. Rizzo M, Nikolic D, Di Pace F, Papanas N, Montano N. GLP-1 receptor agonists, carotid atherosclerosis and retinopathy. Expert Opin Pharmacother. 2017 Jun 21:1-3. [Epub ahead of print]
  2. Pafili K, Maltezos E, Papanas N. Dapagliflozin for the treatment of type 1 diabetes mellitus. Expert Opin Investig Drugs. 2017;26:873-881.
  3. Archontogeorgis K, Nena E, Papanas N, Zissimopoulos A, Voulgaris A, Xanthoudaki M, Manolopoulos V, Froudarakis M, Steiropoulos P. Vitamin D levels in middle-aged patients with obstructive sleep apnoea syndrome. Curr Vasc Pharmacol. 2017 May 28. [Epub ahead of print].
  4. Ziegler D, Edmundson S, Gurieva I, Mankovsky B, Papanas N, Strokov I. Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy. J Diabetes Complications. 2017; 31:1181-1187.
  5. Steiropoulos P, Papanas N. Increased Carotid Intima-Media Thickness in Obstructive Sleep Apnea: An Additional Issue to Consider. Angiology. 2017 Jan 1:3319717705270. [Epub ahead of print]
  6. Ziegler D, Winter K, Strom A, Zhivov A, Allgeier S, Papanas N, Ziegler I, Brüggemann J, Ringel B, Peschel S, Köhler B, Stachs O, Guthoff RF, Roden M; German Diabetes Study (GDS) Group. Spatial analysis improves the detection of early corneal nerve fiber loss in patients with recently diagnosed type 2 diabetes. PLoS One 2017; 12: e0173832.
  7. Pafili K, Maltezos E, Papanas N. NC-stat for the diagnosis of diabetic polyneuropathy. Expert Rev Med Devices 2017; 14: 251-4.
  8. Tsioufis C, Andrikou E, Thomopoulos C, Papanas N, Tousoulis D. Oral Glucose-lowering Drugs and Cardiovascular Outcomes: From the Negative RECORD and ACCORD to Neutral TECOS and Promising EMPA-REG. Curr Vasc Pharmacol 2016 Dec 8. [Epub ahead of print]
  9. Papatheodorou K, Papanas N, Banach M, Papazoglou D, Edmonds M. Complications of Diabetes 2016. J Diabetes Res 2016; 2016: 6989453.
  10. Papanas N, Ziegler D. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain. Expert Opin Emerg Drugs 2016; 21: 393-407.
  11. Pafili K, Maltezos E, Papanas N. Editorial: Limited Utility of the Handgrip Test for the Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy: "There's Time Enough, But None to Spare". Curr Vasc Pharmacol 2017; 15: 74-6.
  12. Panagopoulos P, Papanas N, Maltezos E. Tedizolid in skin and skin structure infections: brave new world? Expert Opin Pharmacother 2016;17:2249-51.
  13. Pafili K, Papanas N. Letter to the Editor Regarding: Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study. Adv Ther 2016; 33: 1848-52.
  14. Doupis J, Papanas N, Cohen A, McFarlan L, Horton E. Pulse Wave Analysis by Applanation Tonometry for the Measurement of Arterial Stiffness. Open Cardiovasc Med J 2016; 10: 188-95.
  15. Vas P, Panagopoulos P, Papanas N. Editorial: "Ah, Wherefore with Infection Should he Live?": Microbial Virulence Factors in Diabetic Foot Ulceration. Curr Vasc Pharmacol 2016; 14: 498-501.
  16. Boglou P, Papanas N, Oikonomou A, Bakali S, Steiropoulos P. Mounier-Kuhn Syndrome in an Elderly Female with Pulmonary Fibrosis. Case Rep Med 2016; 2016: 8708251.
  17. Pafili K, Maltezos E, Papanas N. Pharmacokinetic and pharmacodynamic drug evaluation of tofogliflozin for the treatment of type 2 diabetes. Expert Opin Drug Metab Toxicol 2016 Sep 8. [Epub ahead of print].
  18. Pafili K, Maltezos E, Papanas N. The potential of SGLT2 inhibitors in phase II clinical development for treating type 2 diabetes. Expert Opin Investig Drugs 2016; 25: 1133-52.
  19. Tziomalos K, Ntaios G, Miyakis S, Papanas N, Xanthis A, Agapakis D, Milionis H, Savopoulos C, Maltezos E, Hatzitolios AI. Prophylactic antibiotic treatment in severe acute ischemic stroke: the Antimicrobial chemopRrophylaxis for Ischemic STrokE In MaceDonIa-Thrace Study (ARISTEIDIS). Intern Emerg Med 2016; 11: 953-8.
  20. Chatzikosma G, Pafili K, Demetriou M, Vadikolias K, Maltezos E, Papanas N. Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus. Arch Med Sci 2016; 12: 390-3.
  21. Ziegler D, Schleicher E, Strom A, Knebel B, Fleming T, Nawroth P, Häring HU, Papanas N, Szendrödi J, Müssig K, Al-Hasani H, Roden M; GDS Group. Association of transketolase polymorphisms with measures of polyneuropathy in patients with recently diagnosed diabetes. Diabetes Metab Res Rev 2017; 33(4).
  22. Achimastos A, Alexandrides T, Alexopoulos D, Athyros V, Bargiota A, Bilianou E, Chrysochoou C, Drogari E, Elisaf M, Ganotakis E, Goudevenos I, Ioannidis I, Kolovou G, Kotsis V, Lekakis I, Liberopoulos E, Melidonis A, Nikolaou V, Ntaios G, Papanas N, Pappas S, Pitsavos C, Rallidis L, Richter D, Skoumas I, Tentolouris N, Tousoulis D, Tselepis A, Tsioufis K, Tziakas D, Tziomalos K, Vardas P, Vlachopoulos C, Vlahakos D. Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. Hormones (Athens) 2016; 15: 8-14.
  23. Papanas N, Mikhailidis DP, Steiropoulos P. Obstructive sleep apnea and cardiovascular disease: Is mean platelet volume one of the links? Anatol J Cardiol 2016; 16: 223.
  24. Papanas N, Demetzos C, Pippa N, Maltezos E, Tentolouris N. Efficacy of a New Heparan Sulfate Mimetic Dressing in the Healing of Foot and Lower Extremity Ulcerations in Type 2 Diabetes: A Case Series. Int J Low Extrem Wounds 2016; 15: 63-7
  25. Papanas N, Tsioufis C, Maltezos ES. Editorial: The New Trial EMPAREG-OUTCOMES in Type 2 Diabetes: "and Death Shall Have no Dominion"? Curr Vasc Pharmacol 2016; 14: 316-8.
  26. Baltzis D, Grammatikopoulou MG, Papanas N, Trakatelli CM, Kintiraki E, Hassapidou MN, Manes C. obese patients with type 2 diabetes on conventional versus intensive insulin therapy: efficacy of low-calorie dietary intervention. Adv Ther 2016; 33: 447-59.
  27. Papazafiropoulou A, Anagnostopoulou K, Papanas N, Petropoulou K, Melidonis A. Neck Circumference as a Simple Tool for Assessing Central Obesity in Patients with Type 2 Diabetes Mellitus in Greece - A Descriptive Study. Rev Diabet Stud 2016; 13: 215-6.
  28. Papanas N, Panagopoulos P, Drosos G, Maltezos E. Local antibiotic administration for diabetic foot osteomyelitis. Re: Karri VVSR, Kuppusamy G, Talluri SV, et al. Current and emerging therapies in the management of diabetic foot ulcers. Curr Med Res Opin 2015: published online 7 December 2015, doi: 10.1185/03007995.2015.1128888. Curr Med Res Opin 2016; 32: 585.
  29. Pafili K, Trypsianis G, Papazoglou D, Maltezos E, Papanas N. Simplified Diagnosis of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Using Ewing's Battery. Rev Diabet Stud 2015; 12: 213-9.
  30. Papanas N, Ziegler D. risk factors and comorbidities in diabetic neuropathy: an update 2015. Rev Diabet Stud 2015; 12: 48-62
  31. Ntolios P, Papanas N, Nena E, Boglou P, Koulelidis A, Tzouvelekis A, Xanthoudaki M, Tsigalou C, Froudarakis ME, Bouros D, Mikhailidis DP, Steiropoulos P. Mean Platelet Volume as a surrogate marker for platelet activation in patients with Idiopathic Pulmonary Fibrosis. Clin Appl Thromb Hemost 2016; 22: 346-50.
  32. Kokkinos S, Papazoglou D, Zisimopoulos A, Papanas N, Tiaka E, Antonoglou C, Maltezos E. Retinol Binding Protein-4 and Adiponectin Levels in Thyroid Overt and Subclinical Dysfunction. Exp Clin Endocrinol Diabetes 2016; 124: 87-92.
  33. Papazafiropoulou AK, Papanas N, Melidonis A, Maltezos E. Family history of type 2 diabetes: does having a diabetic parent increase the risk? Curr Diabetes Rev 2017; 13: 19-25.
  34. Pafili K, Gouni-Berthold I, Papanas N. Abdominal aortic aneurysms: do not underestimate the role of diabetes. Expert Rev Cardiovasc Ther 2015; 13: 1289-90.
  35. Pafili K, Gouni-Berthold I, Papanas N, Mikhailidis DP. Abdominal aortic aneurysms and diabetes mellitus. J Diabetes Complications 2015; 29: 1330-6.
  36. Panagopoulos P, Ganitis A, Papanas N, Iosifidou G, Maltsan T, Kioutsouk S, Christakidou E, Maltezos E. Leptospirosis: a report on a series of five autochthonous cases in a Greek region. J Chemother 2016;28:428-31.
  37. Papanas N, Steiropoulos P. Obstructive Sleep Apnea and Diabetic Foot: New Responsibilities? Angiology 2016; 67: 605-6.
  38. Papatheodorou K, Banach M, Edmonds M, Papanas N, Papazoglou D. Complications of Diabetes. J Diabetes Res 2015; 2015: 189525.
  39. Papanas N, Ziegler D. Corneal confocal microscopy: Recent progress in the evaluation of diabetic neuropathy. J Diabetes Investig 2015; 6: 381-9.
  40. Papanas N, Maltezos E. Glycated Hemoglobin as a Risk Factor for Lower Extremity Amputations in Diabetes: "Success Is Counted Sweetest". Int J Low Extrem Wounds 2015; 14: 106-7.
  41. Migdalis I, Leslie D, Mavrogiannaki A, Papanas N, Valensi P, Vlassara H. Diabetes Mellitus 2014. Int J Endocrinol 2015; 2015: 845759.
  42. Papanas N, Maltezos E. Rosuvastatin and Mean Platelet Volume in Diabetes. Angiology 2016; 67: 113-5.
  43. Tavridou A, Georgoulidou A, Roumeliotis A, Roumeliotis S, Giannakopoulou E, Papanas N, Passadakis P, Manolopoulos VG, Vargemezis V. Association of Plasma Adiponectin and Oxidized Low-Density Lipoprotein with Carotid Intima-Media Thickness in Diabetic Nephropathy. J Diabetes Res 2015; 2015: 507265.
  44. Pafili K, Steiropoulos P, Papanas N. The relationship between obstructive sleep apnoea and coronary heart disease. Curr Opin Cardiol 2015 ;30: 439-46.
  45. Papazafiropoulou A, Papanas N, Pappas S, Maltezos E, Mikhailidis DP. Effects of oral hypoglycemic agents on platelet function. J Diabetes Complications 2015; 29: 846-51.
  46. Körei AE, Istenes I, Papanas N, Kempler P. Small-Fiber Neuropathy: A Diabetic Microvascular Complication of Special Clinical, Diagnostic, and Prognostic Importance. Angiology 2016; 67: 49-57.
  47. Papanas N, Pafili K, Maltezos E. Charcot osteoarthropathy and coronary artery disease in diabetes: the twilight of innocence? Acta Diabetol 2016; 53: 123-4.
  48. Terzi I, Papaioannou V, Papanas N, Dragoumanis C, Petala A, Theodorou V, Gioka T, Vargemezis V, Maltezos E, Pneumatikos I. Alpha1-microglobulin as an early biomarker of sepsis-associated acute kidney injury: a prospective cohort study. Hippokratia 2014; 18: 262-8.
  49. Pafili K, Papanas N. Luseogliflozin and other sodium-glucose cotransporter 2 inhibitors: no enemy but time? Expert Opin Pharmacother 2015; 16: 453-6.
  50. Panagopoulos P, Drosos G, Maltezos E, Papanas N. Local antibiotic delivery systems in diabetic foot osteomyelitis: time for one step beyond? Int J Low Extrem Wounds 2015; 14: 87-91.
  51. Steiropoulos P, Papanas N. Obstructive Sleep Apnea and Atrial Fibrillation: Do They Synergistically Increase Cardiovascular Risk? Angiology 2015; 66: 501-2.
  52. Archontogeorgis K, Nena E, Papanas N, Xanthoudaki M, Hatzizisi O, Kyriazis G, Tsara V, Maltezos E, Froudarakis M, Steiropoulos P. Serum Levels of Vascular Endothelial Growth Factor and Insulin-like Growth Factor Binding Protein-3 in Obstructive Sleep Apnea Patients: Effect of Continuous Positive Airway Pressure Treatment. Open Cardiovasc Med J 2015; 9: 133-8.
  53. Archontogeorgis K, Nena E, Papanas N, Steiropoulos P. Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives. Pulm Med 2014; 2014: 930535.
  54. Pafili K, Papanas N. Thermography in the follow up of the diabetic foot: best to weigh the enemy more mighty than he seems. Expert Rev Med Devices 2015; 12: 131-3.
  55. Ziegler D, Papanas N, Vinik AI, Shaw JE. Epidemiology of polyneuropathy in diabetes and prediabetes. Handb Clin Neurol 2014; 126: 3-22.
  56. Papanas N, Ziegler D. Efficacy of α-lipoic acid in diabetic neuropathy. Expert Opin Pharmacother 2014; 15: 2721-31.
  57. Nena E, Steiropoulos P, Papanas N, Kougkas D, Zarogoulidis P, Constantinidis T. Greek financial crisis: From loss of money to loss of sleep? Hippokratia 2014; 18: 135-8.
  58. Papanas N, Mani R. How to cope with the increasing burden of the diabetic foot: "better three hours too soon than a minute too late". Int J Low Extrem Wounds 2014; 13: 171-2.
  59. Katsiki N, Maltezos E, Papanas N. Diabetic foot: lipids, new and old vascular risk markers. J Diabetes Complications 2014; 28: 913-4.
  60. Aloumanis K, Papanas N. Greek financial crisis: consequences in the healthcare of diabetes and its complications. Hippokratia 2014; 18: 4-6.
  61. Pafili K, Papanas N, Maltezos E. Treatment of diabetic complications: how can we learn by seeking and blundering? Angiology 2015; 66: 301-3.
  62. Pafili K, Papanas N, Maltezos E. Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases? Expert Opin Investig Drugs 2014; 23: 1277-84.
  63. Pafili K, Katsiki N, Mikhailidis DP, Papanas N. Serum uric acid as a predictor of vascular complications in diabetes: an additional case for neuropathy. Acta Diabetol 2014; 51: 893-4.
  64. Papanas N, Mikhailidis DP. Mean platelet volume: a predictor of mortality in diabetic and non-diabetic patients with STEMI? J Diabetes Complications 2014; 28: 581-2.
  65. Papanas N, Ziegler D. New vistas in the diagnosis of diabetic polyneuropathy. Endocrine 2014; 47: 690-8.
  66. Pafili K, Papanas N. Tofogliflozin: the road goes ever on. Expert Opin Pharmacother 2014; 15: 1197-201.
  67. Pafili K, Papanas N. The importance of patient compliance with insulin pens: how can a new user-friendly pen help? Expert Opin Drug Deliv 2014; 11: 629-32.
  68. Kakagia DD, Papanas N, Karadimas E, Polychronidis A. Warfarin-induced skin necrosis. Ann Dermatol 2014; 26: 96-8.
  69. Manes C, Papanas N, Exiara T, Katsiki N, Papantoniou S, Kirlaki E, Tsotoulidis S, Kefalogiannis N, Maltezos E. The indicator test Neuropad in the assessment of small and overall nerve fibre dysfunction in patients with type 2 diabetes: a large multicentre study. Exp Clin Endocrinol Diabetes 2014; 122: 195-9.
  70. Migdalis I, Leslie D, Papanas N, Valensi P, Vlassara H. Diabetes mellitus. Int J Endocrinol 2014; 2014: 108419.
  71. Ziegler D, Papanas N, Zhivov A, Allgeier S, Winter K, Ziegler I, Brüggemann J, Strom A, Peschel S, Köhler B, Stachs O, Guthoff RF, Roden M; German Diabetes Study (GDS) Group. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes 2014; 63: 2454-63.
  72. Gouveri E, Katotomichelakis M, Gouveris H, Danielides V, Maltezos E, Papanas N. Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease? Angiology 2014; 65: 869-76.
  73. Papazafiropoulou A, Papanas N, Pappas S, Maltezos E. Role of endogenous GLP-1 and its agonists in osteopenia and osteoporosis: but we little know until tried. Curr Diabetes Rev 2014; 10: 43-7.
  74. Steiropoulos P, Bogiatzi C, Archontogeorgis K, Nena E, Xanthoudaki M, Boglou P, Tzouvelekis A, Papanas N, Tsivgoulis G, Bouros D. Is there evidence of early vascular disease in patients with obstructive sleep apnoea without known comorbidities? Preliminary findings. Open Cardiovasc Med J 2013; 7: 61-8.
  75. Georgakarakos E, Bitza C, Papanas N, Matsagkas M, Lazarides MK. Vascular nursing in Greece: luxury or necessity? Int J Low Extrem Wounds 2013; 12: 180-3.
  76. Gouni-Berthold I, Papanas N, Maltezos E. The role of oral antidiabetic agents and incretin mimetics in type 2 diabetic patients with non-alcoholic fatty liver disease. Curr Pharm Des 2014; 20: 3705-15.
  77. Papanas N, Zissimopoulos A, Maltezos E. (18)F-FDG PET and PET/CT for the diagnosis of diabetic foot osteomyelitis. Hippokratia 2013; 17: 4-6.
  78. Georgiadis GS, Antoniou GA, Georgakarakos EI, Nikolopoulos ES, Papanas N, Trellopoulos G, Iatrou C, Papadopoulou MZ, Lazarides MK. Surgical or endovascular therapy of abdominal penetrating aortic ulcers and their natural history: a systematic review. J Vasc Interv Radiol 2013; 24: 1437-49.
  79. Gouveri E, Papanas N, Marakomichelakis G, Tzavara C, Drakopanagiotakis F, Maltezos E, Diamantopoulos EJ. Post-exercise ankle-brachial index is not an indispensable tool for the detection of peripheral arterial disease in an epidemiological survey. A post-hoc analysis of the Athens Study. Int Angiol. 2013 Oct;32(5):518-25.
  80. Nena E, Papanas N, Steiropoulos P. Undetected obstructive sleep apnoea (OSA) in the workforce and reduced work productivity in OSA: we need to improve screening to see the whole picture. Chron Respir Dis. 2013 Aug;10(3):183
  81. Demetriou M, Papanas N, Panopoulou M, Papatheodorou K, Maltezos E. Determinants of microbial load in infected diabetic foot ulcers: a pilot study. Int J Endocrinol. 2013;2013:858206
  82. Papanas N, Mani R. Advances in infections and wound healing for the diabetic foot: the die is cast. Int J Low Extrem Wounds. 2013 Jun;12(2):83-6.
  83. Papanas N, Maltezos E. Etiology, pathophysiology and classifications of the diabetic Charcot foot. Diabet Foot Ankle. 2013 May 21;4.
  84. Georgakarakos E, Charalampidis D, Kakagia D, Georgiadis GS, Lazarides MK, Papanas N. Current achievements with topical negative pressure to improve wound healing in dehiscent ischemic stumps of diabetic patients: a case series. Int J Low Extrem Wounds. 2013 Jun;12(2):138-45.
  85. Georgakarakos E, Papadaki E, Vamvakerou V, Lytras D, Tsiokani A, Tsolakaki O, Chlimpou D, Papanas N. Training to measure ankle-brachial index at the undergraduate level: can it be successful? Int J Low Extrem Wounds. 2013 Jun;12(2):167-71.
  86. Demetriou M, Papanas N, Panopoulou M, Papatheodorou K, Bounovas A, Maltezos E. Tissue and swab culture in diabetic foot infections: neuropathic versus neuroischemic ulcers. Int J Low Extrem Wounds. 2013 Jun;12(2):87-93.
  87. Papanas N, Ziegler D. Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy. Curr Diab Rep. 2013 Aug;13(4):488-99.
  88. Trakada G, Steiropoulos P, Zarogoulidis P, Nena E, Papanas N, Maltezos E, Bouros D. A fatty meal aggravates apnea and increases sleep in patients with obstructive sleep apnea. Sleep Breath. 2014 Mar;18(1):53-8.
  89. Boglou P, Steiropoulos P, Papanas N, Bouros D. Hypoglycaemia due to interaction of glimepiride with isoniazid in a patient with type 2 diabetes mellitus. BMJ Case Rep. 2013 Apr 16;2013
  90. Steiropoulos P, Papanas N. Continuous positive airway pressure in obstructive sleep apnea syndrome and prehypertension: time to consider early treatment? Angiology. 2014 Feb;65(2):93-4.
  91. Kostapanos MS, Mikhailidis DP, Elisaf MS, Steiropoulos P, Papanas N. Obstructive sleep apnoea syndrome and cardiovascular risk. Arch Med Sci. 2012 Dec 20;8(6):1115-6.
  92. Kostapanos MS, Rizos EC, Papanas N, Maltezos E, Elisaf MS. Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias. Curr Pharm Des. 2013;19(17):3150-60.
  93. Papanas N, Katsiki N, Putz Z, Mikhailidis DP. Diabetes, obesity and vascular disease--an update. Curr Pharm Des. 2013;19(27):4900-3.
  94. Katsiki N, Papanas N, Fonseca VA, Maltezos E, Mikhailidis DP. Uric acid and diabetes: Is there a link? Curr Pharm Des. 2013;19(27):4930-7.
  95. Papanas N, Ziegler D. Polyneuropathy in impaired glucose tolerance: is postprandial hyperglycemia the main culprit? A mini-review. Gerontology. 2013;59(3):193-8.
  96. Georgakarakos E, Papanas N, Papadaki E, Georgiadis GS, Maltezos E, Lazarides MK. Endovascular treatment of critical ischemia in the diabetic foot: new thresholds, new anatomies. Angiology. 2013 Nov;64(8):583-91.
  97. Papanas N, Maltezos E. Antidiabetic treatment: Though lovers be lost, love shall not. World J Diabetes. 2012 Sep 15;3(9):158-60.
  98. Stathias V, Sotiris GR, Karagiannidis I, Bourikas G, Martinis G, Papazoglou D, Tavridou A, Papanas N, Maltezos E, Theodoridis M, Vargemezis V, Manolopoulos VG, Speed WC, Kidd JR, Kidd KK, Drineas P, Paschou P. Exploring genomic structure differences and similarities between the Greek and European HapMap populations: implications for association studies. Ann Hum Genet. 2012 Nov;76(6):472-83.
  99. Monastiriotis C, Papanas N, Veletza S, Maltezos E. APOE gene polymorphisms and diabetic peripheral neuropathy. Arch Med Sci. 2012 Sep 8;8(4):583-8.
  100. Steiropoulos P, Papanas N, Nena E, Xanthoudaki M, Goula T, Froudarakis M, Pita E, Maltezos E, Bouros D. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities. Angiology. 2013 Oct;64(7):535-9.
     
Autoimmune Journal Flyer